3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
1
Overweight
1
Obesity
1
Insulin Resistance
1
Hyperandrogenism
1
Interventions
Metformin
17
Liraglutide
5
semaglutide
3
Exercise
3
Exenatide
3
Diet, Mediterranean
3
Dexamethasone
3
Caloric Restriction
3
Ovidrel
2
Mindfulness-Based Stress Reduction
2
Hydrocortisone
2
Electroacupuncture
2
Docosahexaenoic Acids
2
Diet
2
Cosyntropin
2
sibutramine
1
penclomedine
1
mirabegron
1
lime
1
licogliflozin
1
dapagliflozin
1
Vitamin D
1
Utrogestan
1
Topiramate
1
Tirzepatide
1
Therapeutics
1
Testosterone
1
Surveys and Questionnaires
1
Standard of Care
1
Spironolactone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
licogliflozin
×
Other
×
Clear all
NCT03152591
2021-01-05
PCOS
Novartis
Phase 2
Completed
29 enrolled
24 charts